8-K
filed March 9, 2026, 7:59 PM ET
ticker VERA
CIK 0001831828
leadership
confidence high
sentiment neutral
materiality 0.30
Vera Therapeutics appoints Christopher Hite to Board of Directors
Vera Therapeutics, Inc.
- Christopher Hite appointed as Class III Director effective March 5, 2026.
- Initial option grant for 24,937 shares at $38.85, vesting monthly over three years.
- Annual cash retainer of $45,000, pro-rated for 2026.
- Eligible for annual option grants from 2027: lesser of 18,000 shares or up to $400k in grant date fair value.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-26-098783
- form_type
- 8-K
- ticker
- VERA
- cik
- 0001831828
- company_name
- Vera Therapeutics, Inc.
- filed_at
- 2026-03-09T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:36.432560+00:00
- generated_at
- 2026-05-15T18:07:57.699293+00:00
- sec_items
- ["5.02"]
- event_type
- leadership
- sentiment
- neutral
- materiality_score
- 0.3
- calibrated_materiality_score
- 0.3
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-26-098783
- json_url
- https://secwatch.observer/filing/0001193125-26-098783.json
- markdown_url
- https://secwatch.observer/filing/0001193125-26-098783.md
- text_url
- https://secwatch.observer/filing/0001193125-26-098783.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1831828/000119312526098783/0001193125-26-098783-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1831828/000119312526098783/vera-20260305.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
GOOD
Gladstone Commercial elects George Stelljes as director; board expands to eight
GLADSTONE COMMERCIAL CORP
June 2, 2026, 8:45 AM ET
leadership
Items 5.02, 7.01, 9.01
same SEC item: 5.02
same event type: leadership
similar materiality
Filing page
SEC filing
GAIN
Gladstone Investment Elects George Stelljes to Board, Expands to 8 Directors
GLADSTONE INVESTMENT CORPORATION\DE
June 2, 2026, 8:45 AM ET
leadership
Items 5.02, 7.01, 9.01
same SEC item: 5.02
same event type: leadership
similar materiality
Filing page
SEC filing
LAND
Gladstone Land elects George 'Chip' Stelljes, III as independent director
GLADSTONE LAND Corp
June 2, 2026, 8:45 AM ET
leadership
Items 5.02, 7.01, 9.01
same SEC item: 5.02
same event type: leadership
similar materiality
Filing page
SEC filing
GLAD
Gladstone Capital elects George 'Chip' Stelljes as independent director, board expands to eight
GLADSTONE CAPITAL CORP
June 2, 2026, 8:45 AM ET
leadership
Items 5.02, 7.01, 9.01
same SEC item: 5.02
same event type: leadership
similar materiality
Filing page
SEC filing
OLD DOMINION ELECTRIC COOPERATIVE
Director Belvin Williamson Jr. resigns from Old Dominion Electric Cooperative board, effective July 28, 2026
OLD DOMINION ELECTRIC COOPERATIVE
June 2, 2026, 8:06 AM ET
leadership
Items 5.02
same SEC item: 5.02
same event type: leadership
similar materiality
Filing page
SEC filing
PAGP
Plains GP Holdings announces CAO succession: Montgomery promoted, Herbold retiring
PLAINS GP HOLDINGS LP
June 2, 2026, 6:05 AM ET
leadership
Items 5.02
same SEC item: 5.02
same event type: leadership
similar materiality
Filing page
SEC filing
PAA
Plains All American announces CAO retirement and Montgomery promotion effective Sep 1, 2026
PLAINS ALL AMERICAN PIPELINE LP
June 2, 2026, 6:03 AM ET
leadership
Items 5.02
same SEC item: 5.02
same event type: leadership
similar materiality
Filing page
SEC filing
AHCO
AdaptHealth amends 8-K to disclose COO Daniel McFadden's compensation: base salary raised to $550K, plus RSU grant
AdaptHealth Corp.
June 1, 2026, 9:02 PM ET
leadership
Items 5.02, 9.01
same SEC item: 5.02
same event type: leadership
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.